angiotensin ii has been researched along with imidaprilat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Russell, ST; Sanders, PM; Tisdale, MJ | 1 |
| Ichihara, A; Itoh, H; Kinouchi, K; Kurauchi-Mito, A; Murohashi-Bokuda, K; Narita, T; Nishiyama, A; Sakoda, M; Saleem, MA; Suzuki, F | 1 |
2 other study(ies) available for angiotensin ii and imidaprilat
| Article | Year |
|---|---|
Angiotensin II directly inhibits protein synthesis in murine myotubes.
Topics: Angiotensin II; Animals; Drug Combinations; Imidazolidines; Insulin-Like Growth Factor I; Muscle Fibers, Skeletal; Muscle, Skeletal; Protein Biosynthesis; Vasoconstrictor Agents | 2006 |
Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Fumarates; Humans; Imidazolidines; Phosphorylation; Podocytes; Prorenin Receptor; Receptors, Cell Surface; Renin; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Tetrazoles | 2010 |